跳至主要内容
临床试验/EUCTR2013-004206-26-BE
EUCTR2013-004206-26-BE进行中(未招募)不适用

The effect of methylphenidate (Ritalin ®) on the severity of stuttering. - The effect of methylphenidate (Ritalin ®) on the severity of stuttering.

Vakgroep Huisartsgeneeskunde VUB0 个研究点开始时间: 2014年1月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Men and women
  • development Stuttering
  • At least 18 years old
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 50
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Psychological disorders: depression, psychosis, bipolar disorder
  • Psychogenic or neurogenic stuttering
  • Children under 18 years
  • Use of methylphenidate (now or in the past)
  • Pregnant or breastfeeding
  • AHT (blood pressure above 140/90)
  • Use of benzodiazepines, neuroleptics such as haloperidol, amphetamines, anti-emetics such as metoclopramide and domperidone, L-dopa, MAO inhibitors
  • Stroke or TIA
  • hyperthyroidism
  • Cocaine or other drug use (now or in the past)
  • Drug addiction (now or in the past)
  • Known liver disease

研究者

发起方
Vakgroep Huisartsgeneeskunde VUB

相似试验

The effect of methylphenidate (Ritalin ®) on the... | 临床试验